Coming soon: GLOBAL PHARMA REPORT 2023 – sign up here to be the first one notified!

DAX 40 – looking back at 2022

2022 was a difficult year for companies in the DAX 40 Index. The Russia-Ukraine war, inflation, and individual brand struggles have had an effect on nearly every industry and company. 

Find out if stakeholders are on the same page with brands in regard to how they’ve handled crises by reading the perception brief.

Fill out the form below to download the brief


Follow Caliber

Get our newsletter directly in your inbox